Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Research & Development (2020 - 2025)

Historic Research & Development for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $18.2 million.

  • PROCEPT BioRobotics' Research & Development rose 925.09% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.3 million, marking a year-over-year increase of 900.56%. This contributed to the annual value of $62.3 million for FY2024, which is 2859.27% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Research & Development stood at $18.2 million, which was up 925.09% from $17.6 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Research & Development registered a high of $18.2 million during Q3 2025, and its lowest value of $4.5 million during Q2 2021.
  • For the 5-year period, PROCEPT BioRobotics' Research & Development averaged around $11.1 million, with its median value being $11.6 million (2023).
  • As far as peak fluctuations go, PROCEPT BioRobotics' Research & Development skyrocketed by 11426.86% in 2023, and later skyrocketed by 74.85% in 2025.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Research & Development stood at $5.1 million in 2021, then skyrocketed by 90.74% to $9.7 million in 2022, then surged by 49.72% to $14.5 million in 2023, then grew by 3.93% to $15.1 million in 2024, then rose by 20.72% to $18.2 million in 2025.
  • Its last three reported values are $18.2 million in Q3 2025, $17.6 million for Q2 2025, and $16.4 million during Q1 2025.